The first patient was dosed in the U.S. as part of a clinical trial testing of NK cell therapy candidate AlloNK for lupus nephritis.| Lupus News Today
Lupus Therapeutics is teaming up with Artiva Biotherapeutics on a Phase 1 trial of AlloNK, a natural killer cell therapy for lupus nephritis.| Lupus News Today
AlloNK cells are collected from the umbilical cord blood of healthy donors and cryopreserved for immediate use in outpatient settings.| Lupus News Today